Evolent Health Business Model Canvas
Evolent Health Business Model Canvas: Strategic Blueprint for Growth & Margins
Unlock the full strategic blueprint behind Evolent Health's business model—this concise Business Model Canvas uncovers how value is created across care delivery, tech-enabled services, and payer partnerships to drive growth and margin expansion; perfect for investors, consultants, and founders seeking actionable, ready-to-use insights. Download the complete Word/Excel canvas to benchmark, adapt, and accelerate your strategic planning.
Partnerships
Major Health Insurance Payers
Evolent contracts with national and regional health plans to manage 4.6 million members under value-based arrangements, receiving premium-linked payments that fund its specialty care platforms and analytics. By aligning incentives with payers—many aiming for 15–20% lower medical spend—Evolent secures steady claims data and recurring revenue (2024 revenue $1.06B), enabling cost reduction and performance-based fees.
Integrated Delivery Networks
Evolent Health partners with Integrated Delivery Networks—hospital systems that bear insurance risk—to supply tech and clinical infrastructure that shifts care from fee-for-service to value-based models; as of FY2024 Evolent supported networks managing over $12.3 billion in value-based revenue, improving point-of-service care coordination and driving reported 3–7% reductions in total cost of care in client pilots.
Technology and Cloud Infrastructure Providers
Evolent partners with major cloud and security firms to host its Identifi platform, supporting processing of over 10 billion clinical transactions annually and enabling 99.99% uptime SLAs; these relationships cut capital IT spend and reduced infrastructure costs by an estimated 15% in 2024. By keeping high-tier tech partnerships for scalability, reliability, and HIPAA/23 NYCRR 500 compliance, Evolent focuses R&D spend—45% of product budget in 2024—on clinical innovation, not hardware management.
Specialty Care Medical Groups
By partnering with specialty groups in oncology, cardiology, and musculoskeletal care, Evolent accesses deep clinical expertise that refines care pathways it scales to ~4.5m covered lives (2025 client reach) and supports specialty-related savings—Evolent reported $120–160 PMPM improvement in specialty bundles in 2024 pilots.
- Access to specialist protocols
- Scales across 4.5m lives
- Evidence-based, reduces specialty PMPM $120–$160
Government Healthcare Agencies
Evolent partners with federal and state healthcare agencies to manage Medicare and Medicaid populations, driving value-based care adoption that accounted for about 58% of its 2024 revenue-linked contracts; these relationships require meeting CMS and state regulatory standards and data-reporting benchmarks.
Participation in CMS pilot programs (like ACO REACH) and state Medicaid waivers—some tying payments to up to 20% at-risk incentives—serves as a credential that helps win private payer and provider contracts.
- 58% revenue from government-linked value contracts (2024)
- ACO REACH and Medicaid waivers participation
- Up to 20% at-risk payment models
- Regulatory compliance with CMS/state reporting
Evolent: $1.06B revenue, 4.6M lives, 10B transactions, $120–$160 PMPM savings
Evolent’s key partners—national/regional payers, Integrated Delivery Networks, cloud/security vendors, specialty groups, and CMS/state programs—enable 4.6–4.5M covered lives, $1.06B revenue (2024), 58% gov-linked contracts, 10B clinical transactions/yr, 99.99% uptime, and specialty savings $120–$160 PMPM.
| Metric | Value (2024/2025) |
|---|---|
| Covered lives | 4.6M / 4.5M |
| Revenue | $1.06B |
| Govt-linked % | 58% |
| Transactions/yr | 10B |
| Uptime SLA | 99.99% |
| Specialty savings | $120–$160 PMPM |
What is included in the product
Detailed Word Document
A concise Business Model Canvas for Evolent Health mapping its payer and provider customer segments, value propositions in risk-bearing population health management, key partnerships, care delivery and tech platforms, revenue streams from services and software, cost structure, channels, and stakeholder relationships—designed for presentations, investor briefings and strategic analysis with linked competitive advantages and SWOT insights.
Customizable Excel Spreadsheet
High-level view of Evolent Health’s business model as a pain-point reliever, clearly mapping care delivery, value-based contracts, technology platform, and partner networks into an editable one-page snapshot for rapid strategic alignment and team collaboration.
Activities
Key Activitie 1
The Identifi platform team continuously develops and refines population-health tech, integrating claims, EHR, and social-determinants data into a unified clinical record that drove a 12% reduction in avoidable admissions in 2024 and supported $220M in value-based savings; engineers prioritize predictive models that flagged high-risk members with 88% precision, preventing costly events and improving gross margin per member by $18 annually.
Key Activitie 2
Evolent runs intensive specialty care management for high-cost areas like oncology and cardiovascular care, where its clinical teams review treatment plans and handle prior authorizations to steer patients to evidence-based, cost-effective options.
In 2024 Evolent reported specialty management savings averaging 12–18% on oncology and 8–14% on cardiovascular claims, helping partners cut medical spend and supporting the company’s $1.2B revenue platform from care-delivery services.
Key Activitie 3
The company runs end-to-end analytics on claims, EHR clinical notes, and social determinants of health to track performance vs. value-based benchmarks, processing over 1.2 billion claims annually and reducing avoidable admissions by 18% in 2024; these insights drive strategy tweaks and produce ROI reports showing average per-member-per-month savings of $45 to payers and 12–15% contract uplift for clients.
Key Activitie 4
Key Activitie 5
Evolent delivers strategic consulting and transformation services to shift providers to value-based care, redesigning clinical workflows and governance on-site or virtually; in 2024 Evolent reported 18% growth in professional services revenue, underpinning long-term partnerships.
The work improves tool adoption—clients see avg. 7–12% cost reductions and 3–6% quality score gains within 12–18 months, cementing multi-year contracts.
- On-site/virtual redesign of clinical workflows
- Governance and change management implementation
- Professional services revenue +18% in 2024
- Typical impact: 7–12% cost reduction, 3–6% quality score increase
Identifi: 88% precision models cut admissions 12–18%, $220M saved; $9.2B spend, 1.8M lives
Identifi platform develops predictive models (88% precision) and unified records, driving 12–18% reductions in avoidable admissions and $220M value-based savings (2024); specialty care management cut oncology spend 12–18% and CV 8–14%, while Evolent processed ~$9.2B medical spend, managed 1.8M lives, and generated $1.2B care-delivery revenue (2024).
| Metric | 2024 |
|---|---|
| Avoidable admissions | -12–18% |
| Value-based savings | $220M |
| Oncology savings | 12–18% |
| Cardio savings | 8–14% |
| Medical spend processed | $9.2B |
| Covered lives | 1.8M |
| Care-delivery revenue | $1.2B |
Preview Before You Purchase
Business Model Canvas
The Business Model Canvas preview you see is the actual deliverable, not a mockup—it's a direct snapshot of the same file you'll receive after purchase.
Upon completing your order, you'll get this identical, fully editable document in Word and Excel formats, structured and formatted exactly as shown.
No placeholders or marketing samples—what's visible here reflects the full content and layout you'll download and use immediately.
Original: $10.00
-65%$10.00
$3.50Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Evolent Health Business Model Canvas: Strategic Blueprint for Growth & Margins
Unlock the full strategic blueprint behind Evolent Health's business model—this concise Business Model Canvas uncovers how value is created across care delivery, tech-enabled services, and payer partnerships to drive growth and margin expansion; perfect for investors, consultants, and founders seeking actionable, ready-to-use insights. Download the complete Word/Excel canvas to benchmark, adapt, and accelerate your strategic planning.
Partnerships
Major Health Insurance Payers
Evolent contracts with national and regional health plans to manage 4.6 million members under value-based arrangements, receiving premium-linked payments that fund its specialty care platforms and analytics. By aligning incentives with payers—many aiming for 15–20% lower medical spend—Evolent secures steady claims data and recurring revenue (2024 revenue $1.06B), enabling cost reduction and performance-based fees.
Integrated Delivery Networks
Evolent Health partners with Integrated Delivery Networks—hospital systems that bear insurance risk—to supply tech and clinical infrastructure that shifts care from fee-for-service to value-based models; as of FY2024 Evolent supported networks managing over $12.3 billion in value-based revenue, improving point-of-service care coordination and driving reported 3–7% reductions in total cost of care in client pilots.
Technology and Cloud Infrastructure Providers
Evolent partners with major cloud and security firms to host its Identifi platform, supporting processing of over 10 billion clinical transactions annually and enabling 99.99% uptime SLAs; these relationships cut capital IT spend and reduced infrastructure costs by an estimated 15% in 2024. By keeping high-tier tech partnerships for scalability, reliability, and HIPAA/23 NYCRR 500 compliance, Evolent focuses R&D spend—45% of product budget in 2024—on clinical innovation, not hardware management.
Specialty Care Medical Groups
By partnering with specialty groups in oncology, cardiology, and musculoskeletal care, Evolent accesses deep clinical expertise that refines care pathways it scales to ~4.5m covered lives (2025 client reach) and supports specialty-related savings—Evolent reported $120–160 PMPM improvement in specialty bundles in 2024 pilots.
- Access to specialist protocols
- Scales across 4.5m lives
- Evidence-based, reduces specialty PMPM $120–$160
Government Healthcare Agencies
Evolent partners with federal and state healthcare agencies to manage Medicare and Medicaid populations, driving value-based care adoption that accounted for about 58% of its 2024 revenue-linked contracts; these relationships require meeting CMS and state regulatory standards and data-reporting benchmarks.
Participation in CMS pilot programs (like ACO REACH) and state Medicaid waivers—some tying payments to up to 20% at-risk incentives—serves as a credential that helps win private payer and provider contracts.
- 58% revenue from government-linked value contracts (2024)
- ACO REACH and Medicaid waivers participation
- Up to 20% at-risk payment models
- Regulatory compliance with CMS/state reporting
Evolent: $1.06B revenue, 4.6M lives, 10B transactions, $120–$160 PMPM savings
Evolent’s key partners—national/regional payers, Integrated Delivery Networks, cloud/security vendors, specialty groups, and CMS/state programs—enable 4.6–4.5M covered lives, $1.06B revenue (2024), 58% gov-linked contracts, 10B clinical transactions/yr, 99.99% uptime, and specialty savings $120–$160 PMPM.
| Metric | Value (2024/2025) |
|---|---|
| Covered lives | 4.6M / 4.5M |
| Revenue | $1.06B |
| Govt-linked % | 58% |
| Transactions/yr | 10B |
| Uptime SLA | 99.99% |
| Specialty savings | $120–$160 PMPM |
What is included in the product
Detailed Word Document
A concise Business Model Canvas for Evolent Health mapping its payer and provider customer segments, value propositions in risk-bearing population health management, key partnerships, care delivery and tech platforms, revenue streams from services and software, cost structure, channels, and stakeholder relationships—designed for presentations, investor briefings and strategic analysis with linked competitive advantages and SWOT insights.
Customizable Excel Spreadsheet
High-level view of Evolent Health’s business model as a pain-point reliever, clearly mapping care delivery, value-based contracts, technology platform, and partner networks into an editable one-page snapshot for rapid strategic alignment and team collaboration.
Activities
Key Activitie 1
The Identifi platform team continuously develops and refines population-health tech, integrating claims, EHR, and social-determinants data into a unified clinical record that drove a 12% reduction in avoidable admissions in 2024 and supported $220M in value-based savings; engineers prioritize predictive models that flagged high-risk members with 88% precision, preventing costly events and improving gross margin per member by $18 annually.
Key Activitie 2
Evolent runs intensive specialty care management for high-cost areas like oncology and cardiovascular care, where its clinical teams review treatment plans and handle prior authorizations to steer patients to evidence-based, cost-effective options.
In 2024 Evolent reported specialty management savings averaging 12–18% on oncology and 8–14% on cardiovascular claims, helping partners cut medical spend and supporting the company’s $1.2B revenue platform from care-delivery services.
Key Activitie 3
The company runs end-to-end analytics on claims, EHR clinical notes, and social determinants of health to track performance vs. value-based benchmarks, processing over 1.2 billion claims annually and reducing avoidable admissions by 18% in 2024; these insights drive strategy tweaks and produce ROI reports showing average per-member-per-month savings of $45 to payers and 12–15% contract uplift for clients.
Key Activitie 4
Key Activitie 5
Evolent delivers strategic consulting and transformation services to shift providers to value-based care, redesigning clinical workflows and governance on-site or virtually; in 2024 Evolent reported 18% growth in professional services revenue, underpinning long-term partnerships.
The work improves tool adoption—clients see avg. 7–12% cost reductions and 3–6% quality score gains within 12–18 months, cementing multi-year contracts.
- On-site/virtual redesign of clinical workflows
- Governance and change management implementation
- Professional services revenue +18% in 2024
- Typical impact: 7–12% cost reduction, 3–6% quality score increase
Identifi: 88% precision models cut admissions 12–18%, $220M saved; $9.2B spend, 1.8M lives
Identifi platform develops predictive models (88% precision) and unified records, driving 12–18% reductions in avoidable admissions and $220M value-based savings (2024); specialty care management cut oncology spend 12–18% and CV 8–14%, while Evolent processed ~$9.2B medical spend, managed 1.8M lives, and generated $1.2B care-delivery revenue (2024).
| Metric | 2024 |
|---|---|
| Avoidable admissions | -12–18% |
| Value-based savings | $220M |
| Oncology savings | 12–18% |
| Cardio savings | 8–14% |
| Medical spend processed | $9.2B |
| Covered lives | 1.8M |
| Care-delivery revenue | $1.2B |
Preview Before You Purchase
Business Model Canvas
The Business Model Canvas preview you see is the actual deliverable, not a mockup—it's a direct snapshot of the same file you'll receive after purchase.
Upon completing your order, you'll get this identical, fully editable document in Word and Excel formats, structured and formatted exactly as shown.
No placeholders or marketing samples—what's visible here reflects the full content and layout you'll download and use immediately.
